Results 191 to 200 of about 170,488 (349)
Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino +3 more
wiley +1 more source
Contraceptives in chronic lymphocytic leukemia (CLL): a narrative review. [PDF]
Al-Shibly R +4 more
europepmc +1 more source
Chronic Lymphocytic Leukemia B Cells Can Express CD40 Ligand and Demonstrate T-Cell Type Costimulatory Capacity [PDF]
Elaine J. Schattner +6 more
openalex +1 more source
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu +8 more
wiley +1 more source
V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia [PDF]
Amlot, P +8 more
core
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing [PDF]
Jennifer M. Grants +17 more
openalex +1 more source
CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li +8 more
wiley +1 more source
A novel presentation of ocular chronic lymphocytic leukemia. [PDF]
Nakhleh LA +5 more
europepmc +1 more source
BRAC2 gene deletion is rare in chronic lymphocytic leukemia [PDF]
Emanuela Pilozzi +3 more
openalex +1 more source

